Farallon Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
2020
Q1
$341K Sell
2019
Q4
$16.3M Sell
2019
Q3
$11.5M Buy
2019
Q2
$10.6M Buy
2015
Q2
Sell
2015
Q1
$758K Sell
2014
Q4
$3.91M Hold
2014
Q3
$2.09M Hold
2014
Q2
$3.2M Sell
2014
Q1
$3.24M Buy